Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose pioglitazone + flutamide + metformin versus ethinylestradiol + cyproterone acetate in adolescents with ovarian hyperandrogenism and hyperinsulinism
2009-012226-37Phase 2Active
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pioglitazone, flutamide, metformin, ethinyl estradiol and cyproterone in Hyperandrogenism and hyperinsulinism (HI) (2 arms), sponsored by Sant Joan de Déu Hospital. Primary endpoints: Body mass index, Dietary data and 4 more. Started Oct 2009; status: active.
02
Drugs
pioglitazoneflutamidemetforminethinyl estradiolcyproterone
03
Conditions
Hyperandrogenismhyperinsulinism (HI)
Beyond the preview
Go deeper on 2009-012226-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012226-37.